Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

753958

	registered interest
	date	19/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radioisotopes: Imports
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government (1) what assessment they have made of the potential impact of not reaching agreement with the EU by April 2019 on the supply of the radioisotope molybdenum-99 used to produce technetium-99m which is required for over 80 per cent of diagnostic medicine procedures in the UK; (2) what assessment they have made of the potential impact of delays or disruption to the supply of diagnostic medicine procedures that may result; and (3) what contingency plans they have put in place to mitigate such delays or disruption to that supply after Brexit.
	tabling member printed	Lord Mendelsohn
	uin	HL1104
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>The Government is fully aware of the importance of molybdenum-99 and the reliance on this medical radioisotope for diagnostic procedures in the National Health Service. The United Kingdom’s ability to import medical isotopes from Europe and the rest of the world will not be affected by withdrawal from Euratom. It is in everyone’s interest to not disrupt the timely access of treatment to patients and to ensure that cross-border trade with the European Union and Euratom is as frictionless as possible.</p> answering member printed Lord O'Shaughnessy question first answered 31/07/2017 13:38:56 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4286 label Biography information for Lord Mendelsohn

748834

	registered interest
	date	05/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how many diagnoses of HIV were made as a result of the admission of a patient to a hospital accident and emergency department in each of the last five for which figures are available.
	tabling member printed	Lord Black of Brentwood
	uin	HL497
	answer	answer is ministerial correction date of answer 18/07/2017 answer text <p>It is not possible to identify HIV in the Hospital Episodes Statistics (HES) accident and emergency (A&amp;E) Diagnosis scheme. A table showing unpublished data collected through the HIV and AIDS Reporting System with Public Health England, is attached due to the size of the data.</p> answering member printed Lord O'Shaughnessy question first answered 18/07/2017 16:07:54 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name HL497 table formatted.docx title HIV diagnoses in A&E 2011-15
	tabling member	4171 label Biography information for Lord Black of Brentwood

750578

	registered interest
	date	11/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Small Businesses: Loans
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how many ectopic pregnancies have been treated in each of the last 10 years, broken down by NHS regions in England.
	tabling member printed	Baroness Taylor of Bolton
	uin	HL710
	answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>The data requested cannot be provided by National Health Service region as regional boundaries have changed during this period. A table showing finished admissions episodes with a primary diagnosis of ectopic pregnancy by Government Office Region has been attached due to the size of the data.</p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 13:49:59 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name HL710 formatted table.docx title Finished admissions episodes ectopic pregnancy
	tabling member	407 label Biography information for Baroness Taylor of Bolton

748833

	registered interest
	date	05/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how many hospital admissions for acute anxiety have been recorded in each of the last five years for which figures are available.
	tabling member printed	Lord Black of Brentwood
	uin	HL496
	answer	answer is ministerial correction date of answer 18/07/2017 answer text <p>The following table shows the number of finished admission episodes (FAEs) with a primary diagnosis of acute anxiety from 2011/12 to 2015/16.</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Sum of FAEs</p></td></tr><tr><td><p>2011-12</p></td><td><p>8,662</p></td></tr><tr><td><p>2012-13</p></td><td><p>8,680</p></td></tr><tr><td><p>2013-14</p></td><td><p>9,293</p></td></tr><tr><td><p>2014-15</p></td><td><p>9,874</p></td></tr><tr><td><p>2015-16</p></td><td><p>10,199</p></td></tr></tbody></table><p><em>Source</em>: Hospital Episode Statistics, NHS Digital</p><p> </p><ol><li>A FAE is the first period of admitted patient care under one consultant within one healthcare provider.</li><li>FAEs are counted against the year or month in which the admission episode finishes.</li><li>Admissions do not represent the number of patients, as a person may have more than one admission within the period.</li></ol> answering member printed Lord O'Shaughnessy question first answered 18/07/2017 10:46:48 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4171 label Biography information for Lord Black of Brentwood

751979

	registered interest
	date	13/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Financial Services: Greater London
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how many individuals infected with blood contaminated by hepatitis C or HIV in the 1970s and 1980s remain alive.
	tabling member printed	Lord Black of Brentwood
	uin	HL814
	answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>The Department does not hold this information.</p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 15:09:01 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4171 label Biography information for Lord Black of Brentwood

755111

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Secure Psychiatric Units: Ethnic Groups
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how many patients from BME backgrounds spent a period of their care in locked wards in England during each of the last three years for which figures are available.
	tabling member printed	Lord Boateng
	uin	HL1119
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>Data on the number of BME patients being treated in locked rehabilitation wards in England is not collected centrally, though we would expect trusts to pay close attention to such data.</p><p> </p><p>The Government welcomes the findings of the Care Quality Commission’s (CQC’s) report and shares its concerns about inappropriate use of locked rehabilitation wards. The department will consider the implications in discussion with NHS England, NHS Improvement and the CQC.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL1118 HL1120 question first answered 31/07/2017 13:25:20 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	147 label Biography information for Lord Boateng

748867

	registered interest
	date	05/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how many people commenced treatment for hepatitis C in the financial year 2016–17 broken down by operational delivery network area.
	tabling member printed	Baroness Randerson
	uin	HL530
	answer	answer is ministerial correction date of answer 17/07/2017 answer text <p>The following table shows the number of people who commenced treatment in the financial year 2016-17 broken down by operational delivery network (ODN) area. The data has been collected by NHS England and was previously unpublished.</p><p> </p><table><tbody><tr><td><p>Network(ODN)</p></td><td><p>Actual</p></td></tr><tr><td><p>Barts</p></td><td><p>494</p></td></tr><tr><td><p>Birmingham</p></td><td><p>748</p></td></tr><tr><td><p>Bristol and Severn Hep C ODN</p></td><td><p>326</p></td></tr><tr><td><p>Cheshire and Merseyside</p></td><td><p>347</p></td></tr><tr><td><p>Eastern Hepatitis Network</p></td><td><p>586</p></td></tr><tr><td><p>Greater Manchester and Eastern Cheshire</p></td><td><p>687</p></td></tr><tr><td><p>Humberside and North Yorkshire</p></td><td><p>377</p></td></tr><tr><td><p>Kent Network via Kings</p></td><td><p>154</p></td></tr><tr><td><p>Lancashire and South Cumbria</p></td><td><p>330</p></td></tr><tr><td><p>Leicester</p></td><td><p>255</p></td></tr><tr><td><p>North Central London Viral Hepatitis Network</p></td><td><p>730</p></td></tr><tr><td><p>North East and Cumbria</p></td><td><p>395</p></td></tr><tr><td><p>Nottingham</p></td><td><p>383</p></td></tr><tr><td><p>South Thames Hepatitis Network</p></td><td><p>870</p></td></tr><tr><td><p>South Yorkshire</p></td><td><p>340</p></td></tr><tr><td><p>Surrey Hepatitis Services</p></td><td><p>154</p></td></tr><tr><td><p>Sussex Hepatology Network</p></td><td><p>241</p></td></tr><tr><td><p>SW Peninsula Hepatitis C ODN</p></td><td><p>328</p></td></tr><tr><td><p>Thames Valley Hep C ODN</p></td><td><p>347</p></td></tr><tr><td><p>Wessex Hep C ODN</p></td><td><p>341</p></td></tr><tr><td><p>West London</p></td><td><p>562</p></td></tr><tr><td><p>West Yorkshire</p></td><td><p>445</p></td></tr><tr><td><p>Total</p></td><td><p>9,440</p></td></tr></tbody></table><p> </p> answering member printed Lord O'Shaughnessy question first answered 17/07/2017 11:52:58 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4230 label Biography information for Baroness Randerson

751974

	registered interest
	date	13/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	European Committee for Standardization
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how much funding was allocated in 2016–17 to treat alcohol addiction in prisons.
	tabling member printed	Lord Farmer
	uin	HL809
	answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>The Department does not hold this information.</p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 11:03:13 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4321 label Biography information for Lord Farmer

752468

	registered interest
	date	17/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Parkinson's Disease: Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how much the NHS pays for a one year supply of Apomorphine for a patient with Parkinson's Disease; how much they estimate it costs to manufacture a year's supply of that drug; what assessment they have made of the difficulties of manufacturing Apomorphine to clinical standards; and whether they intend to take any steps to reduce the cost of that drug to the NHS.
	tabling member printed	Lord Lucas
	uin	HL914
	answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>The drug cost to the National Health Service for a one year supply of Apomorphine for a patient with Parkinson's Disease is estimated to be in the region of £5,300 and £9,000, based on the usual daily dose of 3 – 30mg. However, the maximum daily is 100mg, so the annual cost for some patient’s treatment may be higher.</p><p>We have no estimate of the cost of manufacture. We are not aware of any particular issues relating to the manufacture of this drug. Pharmaceutical companies participate in either the voluntary pharmaceutical price regulation scheme (PPRS) or the statutory medicines price regulation scheme, both of which regulate the cost of medicines to the NHS. Products covered by the statutory scheme are subject to a 15% cut to their list price. Companies in the PPRS pay a percentage of sales to the Government when growth in NHS spending on medicines exceeds an agreed level. NHS purchasers may also negotiate discounts with pharmaceutical companies in addition to national price regulation.</p><p> </p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 15:12:09 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1879 label Biography information for Lord Lucas

748866

	registered interest
	date	05/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how much was spent by the NHS on commissioning treatments for hepatitis C in the financial year 2016–17.
	tabling member printed	Baroness Randerson
	uin	HL529
	answer	answer is ministerial correction date of answer 18/07/2017 answer text <p>The hepatitis C drug treatment bill for 2016-17 was in excess of £200 million.</p> answering member printed Lord O'Shaughnessy question first answered 18/07/2017 10:46:20 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4230 label Biography information for Baroness Randerson